The beneficial effect of myostatin deficiency on maximal muscle force and power is attenuated with age

Experimental Gerontology

Volumn 48, Issue 2, 2013, Pages 183-190

  Schirwis, E ^a   Agbulut, O ^b   Vadrot, Nathalie ^b   Mouisel, E ^a   Hourde C ^a   Bonnieu, A ^c   Butler Browne, G ^a   Amthor, H ^a,b   Ferry, A ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c University of Montpellier   (France)

Author keywords

Aging; Maximal force; Maximal power; Myostatin deficiency; Sex; Skeletal muscle

Indexed keywords

MYOSTATIN;

AGE DISTRIBUTION; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; KNOCKOUT MOUSE; MALE; MOUSE; MUSCLE FUNCTION; MUSCLE HYPERTROPHY; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; PESTICIDE RESISTANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; SEX DIFFERENCE; WILD TYPE;

AGE FACTORS; AGING; ANIMALS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOSTATIN; SEX FACTORS;

MUS;

EID: 84872547581     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.11.008     Document Type: Article

References (47)

1. Agbulut O., Noirez P., Beaumont F., Butler-Browne G. Myosin heavy chain isoforms in postnatal muscle development of mice. Biol. Cell 2003, 95:399-406.
2. Akpan I., Goncalves M.D., Dhir R., Yin X., Pistilli E.E., Bogdanovich S., Khurana T.S., Ucran J., Lachey J., Ahima R.S. The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int. J. Obes. (Lond) 2009, 33:1265-1273.
3. Amthor H., Macharia R., Navarrete R., Schuelke M., Brown S.C., Otto A., Voit T., Muntoni F., Vrbova G., Partridge T., Zammit P., Bunger L., Patel K. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1835-1840.
4. Baligand C., Gilson H., Menard J.C., Schakman O., Wary C., Thissen J.P., Carlier P.G. Functional assessment of skeletal muscle in intact mice lacking myostatin by concurrent NMR imaging and spectroscopy. Gene Ther. 2010, 17:328-337.
5. Butler-Browne G.S., Whalen R.G. Myosin isozyme transitions occurring during the postnatal development of the rat soleus muscle. Dev. Biol. 1984, 102:324-334.
6. Chambon C., Duteil D., Vignaud A., Ferry A., Messaddeq N., Malivindi R., Kato S., Chambon P., Metzger D. Myocytic androgen receptor controls the strength but not the mass of limb muscles. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14327-14332.
7. Chan S., Head S.I. Age- and gender-related changes in contractile properties of non-atrophied EDL muscle. PLoS One 2010, 5:e12345.
8. D'Antona G., Brocca L., Pansarasa O., Rinaldi C., Tupler R., Bottinelli R. Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy. J. Physiol. 2007, 584:997-1009.
9. Degens H., Veerkamp J.H. Changes in oxidative capacity and fatigue resistance in skeletal muscle. Int. J. Biochem. 1994, 26:871-878.
10. Durieux A.C., Vignaud A., Prudhon B., Viou M.T., Beuvin M., Vassilopoulos S., Fraysse B., Ferry A., Laine J., Romero N.B., Guicheney P., Bitoun M. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice. Hum. Mol. Genet. 2010, 19:4820-4836.
11. Felicio L.S., Nelson J.F., Finch C.E. Longitudinal studies of estrous cyclicity in aging C57BL/6J mice: II. Cessation of cyclicity and the duration of persistent vaginal cornification. Biol. Reprod. 1984, 31:446-453.
12. Fugier C., Klein A.F., Hammer C., Vassilopoulos S., Ivarsson Y., Toussaint A., Tosch V., Vignaud A., Ferry A., Messaddeq N., Kokunai Y., Tsuburaya R., de la Grange P., Dembele D., Francois V., Precigout G., Boulade-Ladame C., Hummel M.C., de Munain A.L., Sergeant N., Laquerriere A., Thibault C., Deryckere F., Auboeuf D., Garcia L., Zimmermann P., Udd B., Schoser B., Takahashi M.P., Nishino I., Bassez G., Laporte J., Furling D., Charlet-Berguerand N. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat. Med. 2011, 17:720-725.
13. Gay S., Jublanc E., Bonnieu A., Bacou F. Myostatin deficiency is associated with an increase in number of total axons and motor axons innervating mouse tibialis anterior muscle. Muscle Nerve 2012, 45:698-704.
14. Gentry B.A., Ferreira J.A., Phillips C.L., Brown M. Hindlimb skeletal muscle function in myostatin-deficient mice. Muscle Nerve 2011, 43:49-57.
15. Gilson H., Schakman O., Combaret L., Lause P., Grobet L., Attaix D., Ketelslegers J.M., Thissen J.P. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 2007, 148:452-460.
16. Gokhin D.S., Ward S.R., Bremner S.N., Lieber R.L. Quantitative analysis of neonatal skeletal muscle functional improvement in the mouse. J. Exp. Biol. 2008, 211:837-843.
17. Goncalves M.D., Pistilli E.E., Balduzzi A., Birnbaum M.J., Lachey J., Khurana T.S., Ahima R.S. Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition. PLoS One 2010, 5:e12707.
18. Goodman C.A., Blazev R., Kemp J., Stephenson G.M. E-C coupling and contractile characteristics of mechanically skinned single fibres from young rats during rapid growth and maturation. Pflugers Arch. 2008, 456:1217-1228.
19. Greising S.M., Carey R.S., Blackford J.E., Dalton L.E., Kosir A.M., Lowe D.A. Estradiol treatment, physical activity, and muscle function in ovarian-senescent mice. Exp. Gerontol. 2011, 46:685-693.
20. Grobet L., Pirottin D., Farnir F., Poncelet D., Royo L.J., Brouwers B., Christians E., Desmecht D., Coignoul F., Kahn R., Georges M. Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene. Genesis 2003, 35:227-238.
21. Hakim C.H., Duan D. Gender differences in contractile and passive properties of mdx extensor digitorum longus muscle. Muscle Nerve 2012, 45:250-256.
22. Hennebry A., Berry C., Siriett V., O'Callaghan P., Chau L., Watson T., Sharma M., Kambadur R. Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression. Am. J. Physiol. Cell Physiol. 2009, 296:C525-C534.
23. Hoogaars W., Mouisel E., Pasternack A., Hulmi J.J., Relizani K., Schuelke M., Schirwis E., Garcia L., Ritvos O., Ferry A., t Hoen P.A., Amthor H. Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin type IIB receptor in mdx mice. Hum. Gene Ther. 2012 Sep 24, 23(12):1269-1279.
24. Hourde C., Jagerschmidt C., Clement-Lacroix P., Vignaud A., Ammann P., Butler-Browne G.S., Ferry A. Androgen replacement therapy improves function in male rat muscles independently of hypertrophy and activation of the Akt/mTOR pathway. Acta Physiol (Oxf.) 2009, 195:471-482.
25. Koo T., Malerba A., Athanasopoulos T., Trollet C., Boldrin L., Ferry A., Popplewell L., Foster H., Foster K., Dickson G. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of alpha1-syntrophin and alpha-dystrobrevin in skeletal Muscles of mdx mice. Hum. Gene Ther. 2011, 22(11):1379-1388.
26. Lynch G.S., Hinkle R.T., Chamberlain J.S., Brooks S.V., Faulkner J.A. Force and power output of fast and slow skeletal muscles from mdx mice 6-28months old. J. Physiol. 2001, 535:591-600.
27. Matsakas A., Macharia R., Otto A., Elashry M.I., Mouisel E., Romanello V., Sartori R., Amthor H., Sandri M., Narkar V., Patel K. Exercise training attenuates the hypermuscular phenotype and restores skeletal muscle function in the myostatin null mouse. Exp. Physiol. 2012, 97:125-140.
28. McMahon C.D., Popovic L., Jeanplong F., Oldham J.M., Kirk S.P., Osepchook C.C., Wong K.W., Sharma M., Kambadur R., Bass J.J. Sexual dimorphism is associated with decreased expression of processed myostatin in males. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E377-E381.
29. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
30. Mendias C.L., Marcin J.E., Calerdon D.R., Faulkner J.A. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J. Appl. Physiol. 2006, 101:898-905.
31. Mendias C.L., Kayupov E., Bradley J.R., Brooks S.V., Claflin D.R. Decreased specific force and power production of muscle fibers from myostatin-deficient mice are associated with a suppression of protein degradation. J. Appl. Physiol. 2011, 111:185-191.
32. Moran A.L., Warren G.L., Lowe D.A. Soleus and EDL muscle contractility across the lifespan of female C57BL/6 mice. Exp. Gerontol. 2005, 40:966-975.
33. Mouisel E., Blondet B., Escourrou P., Chatonnet A., Molgo J., Ferry A. Outcome of acetylcholinesterase deficiency for neuromuscular functioning. Neurosci. Res. 2006, 55:389-396.
34. Murphy K.T., Koopman R., Naim T., Leger B., Trieu J., Ibebunjo C., Lynch G.S. Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J. 2010, 24:4433-4442.
35. Personius K.E., Jayaram A., Krull D., Brown R., Xu T., Han B., Burgess K., Storey C., Shah B., Tawil R., Welle S. Grip force, EDL contractile properties, and voluntary wheel running after postdevelopmental myostatin depletion in mice. J. Appl. Physiol. 2010, 109:886-894.
36. Ploquin C., Chabi B., Fouret G., Vernus B., Feillet-Coudray C., Coudray C., Bonnieu A., Ramonatxo C. Lack of myostatin alters intermyofibrillar mitochondria activity, unbalances redox status, and impairs tolerance to chronic repetitive contractions in muscle. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E1000-E1008.
37. Qaisar R., Renaud G., Morine K., Barton E.R., Sweeney H.L., Larsson L. Is functional hypertrophy and specific force coupled with the addition of myonuclei at the single muscle fiber level?. FASEB J. 2012, 26:1077-1085.
38. Risson V., Mazelin L., Roceri M., Sanchez H., Moncollin V., Corneloup C., Richard-Bulteau H., Vignaud A., Baas D., Defour A., Freyssenet D., Tanti J.F., Le-Marchand-Brustel Y., Ferrier B., Conjard-Duplany A., Romanino K., Bauche S., Hantai D., Mueller M., Kozma S.C., Thomas G., Ruegg M.A., Ferry A., Pende M., Bigard X., Koulmann N., Schaeffer L., Gangloff Y.G. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J. Cell Biol. 2009, 187:859-874.
39. Savage K.J., McPherron A.C. Endurance exercise training in myostatin null mice. Muscle Nerve 2010, 42:355-362.
40. Siriett V., Platt L., Salerno M.S., Ling N., Kambadur R., Sharma M. Prolonged absence of myostatin reduces sarcopenia. J. Cell. Physiol. 2006, 209:866-873.
41. Trollet C., Anvar S.Y., Venema A., Hargreaves I.P., Foster K., Vignaud A., Ferry A., Negroni E., Hourde C., Baraibar M.A., t Hoen P.A., Davies J.E., Rubinsztein D.C., Heales S.J., Mouly V., van der Maarel S.M., Butler-Browne G., Raz V., Dickson G. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres. Hum. Mol. Genet. 2010, 19:2191-2207.
42. van Wessel T., de Haan A., van der Laarse W.J., Jaspers R.T. The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?. Eur. J. Appl. Physiol. 2010, 110:665-694.
43. Wagner K.R., McPherron A.C., Winik N., Lee S.J. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann. Neurol. 2002, 52:832-836.
44. Wagner K.R., Liu X., Chang X., Allen R.E. Muscle regeneration in the prolonged absence of myostatin. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:2519-2524.
45. Wang Q., McPherron A.C. Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation. J. Physiol. 2012, 590:2151-2165.
46. White R.B., Bierinx A.S., Gnocchi V.F., Zammit P.S. Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev. Biol. 2010, 10:21.
47. Whittemore L.A., Song K., Li X., Aghajanian J., Davies M., Girgenrath S., Hill J.J., Jalenak M., Kelley P., Knight A., Maylor R., O'Hara D., Pearson A., Quazi A., Ryerson S., Tan X.Y., Tomkinson K.N., Veldman G.M., Widom A., Wright J.F., Wudyka S., Zhao L., Wolfman N.M. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem. Biophys. Res. Commun. 2003, 300:965-971.